Skip to main content
Erschienen in: Journal of Sol-Gel Science and Technology 1/2014

01.01.2014 | Original Paper

Sustained release drug delivery using supramolecular hydrogels of the triblock copolymer PCL–PEG–PCL and α-cyclodextrin

verfasst von: Sayyed A. Sajadi Tabassi, Farnaz Sadat Mirzazadeh Tekie, Farzin Hadizadeh, Rahof Rashid, Elham Khodaverdi, Seyed Ahmad Mohajeri

Erschienen in: Journal of Sol-Gel Science and Technology | Ausgabe 1/2014

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Supramolecular hydrogels (SMGel) have attracted much attention as a drug and gene delivery system in recent years. In this study, SMGels based on the tri-block copolymer of poly-ε-caprolactone–polyethylene glycol–poly-ε-caprolactone (PCL–PEG–PCL) and α-cyclodextrin (α-CD) were prepared and evaluated for the delivery of two model drugs, naltrexone hydrochloride and vitamin B12. Tri-block copolymers were synthesized easily in 15 min by ring-opening polymerization using the microwave irradiation technique, and their structures were determined by gel permeation chromatography and nuclear magnetic resonance methods. SMGels composed of various concentrations of the copolymer and α-CD were prepared and characterized for their rheological behaviour, their gel formation time and in vitro drug release profile. The results indicated that copolymers with a PCL to PEG ratio of 1:4 are suitable for SMGel preparation. The most viscose system with good syringeability was prepared by mixing 12 % wt α-CD and 10 % wt of copolymer. The gelation was found to occur within a minute after mixing. The viscosity of the hydrogel systems was determined as a function of shear rate. Finally, in vitro B12 release through the hydrogel systems was studied. Up to 80 % of Vitamin B12 was released through this system during a period of 20 days. Rheological evaluation revealed that the hydrogel has shear thinning properties, and the system regained its ground rheological state in a time dependent manner. Polymer concentration did not affect the drug release profiles. Finally, it was concluded that such systems are appropriate drug delivery systems due to their ability to provide a controlled drug release profile and their shear thinning thixotropic behaviour, which makes them syringeable and injectable.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Higashi T, Hirayama F, Misumi S, Arima H, Uekama K (2008) Biomaterials 29:3866CrossRef Higashi T, Hirayama F, Misumi S, Arima H, Uekama K (2008) Biomaterials 29:3866CrossRef
3.
Zurück zum Zitat Huh KM, Cho YW, Chung H, Kwon IC, Jeong SY, Ooya T, Lee WK, Sasaki S, Yui N (2004) Macromol Biosci 4:92CrossRef Huh KM, Cho YW, Chung H, Kwon IC, Jeong SY, Ooya T, Lee WK, Sasaki S, Yui N (2004) Macromol Biosci 4:92CrossRef
4.
Zurück zum Zitat Ma D, Zhang H-B, Chen D-H, Zhang L-M (2011) J Colloid Interface Sci 364:566CrossRef Ma D, Zhang H-B, Chen D-H, Zhang L-M (2011) J Colloid Interface Sci 364:566CrossRef
5.
Zurück zum Zitat Michel D, Chitanda JM, Balogh R, Yang P, Singh J, Das U, El-Aneed A, Dimmock J, Verrall R, Badea I (2012) Eur J Pharm Biopharm 81:548CrossRef Michel D, Chitanda JM, Balogh R, Yang P, Singh J, Das U, El-Aneed A, Dimmock J, Verrall R, Badea I (2012) Eur J Pharm Biopharm 81:548CrossRef
7.
10.
13.
15.
Zurück zum Zitat Waterman KC, Goeken GS, Konagurthu S, Likar MD, MacDonald BC, Mahajan N, Swaminathan V (2011) J Control Release 152:264CrossRef Waterman KC, Goeken GS, Konagurthu S, Likar MD, MacDonald BC, Mahajan N, Swaminathan V (2011) J Control Release 152:264CrossRef
16.
18.
Zurück zum Zitat Volpicelli Jr A A I H M O B C P (1992) Archives of General Psychiatry 49: 876 Volpicelli Jr A A I H M O B C P (1992) Archives of General Psychiatry 49: 876
19.
Zurück zum Zitat Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen Ø, Waal H (2009) Br J Psychiatry 194:541CrossRef Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen Ø, Waal H (2009) Br J Psychiatry 194:541CrossRef
20.
21.
Zurück zum Zitat van Brussel G (2001) Ned Tijdschr Geneeskd 145:1452 van Brussel G (2001) Ned Tijdschr Geneeskd 145:1452
22.
Zurück zum Zitat Khodaverdi E, Akbari A, Tekie FSM, Mohajeri SA, Zohuri G, Hadizadeh F (2013) PDA J Pharm Sci Technol 67:135CrossRef Khodaverdi E, Akbari A, Tekie FSM, Mohajeri SA, Zohuri G, Hadizadeh F (2013) PDA J Pharm Sci Technol 67:135CrossRef
23.
Zurück zum Zitat Khodaverdi E, Golmohammadian A, Mohajeri S A, Zohuri G, Mirzazadeh Tekie FS, Hadizadeh F (2012) ISRN Pharm: 976879 Khodaverdi E, Golmohammadian A, Mohajeri S A, Zohuri G, Mirzazadeh Tekie FS, Hadizadeh F (2012) ISRN Pharm: 976879
24.
Zurück zum Zitat Gong C, Shi S, Wu L, Gou M, Yin Q, Guo Q, Dong P, Zhang F, Luo F, Zhao X, Wei Y, Qian Z (2009) Acta Biomater 5:3358CrossRef Gong C, Shi S, Wu L, Gou M, Yin Q, Guo Q, Dong P, Zhang F, Luo F, Zhao X, Wei Y, Qian Z (2009) Acta Biomater 5:3358CrossRef
25.
Zurück zum Zitat Gong C, Shi S, Dong P, Kan B, Gou M, Wang X, Li X, Luo F, Zhao X, Wei Y, Qian Z (2009) Int J Pharm 365:89CrossRef Gong C, Shi S, Dong P, Kan B, Gou M, Wang X, Li X, Luo F, Zhao X, Wei Y, Qian Z (2009) Int J Pharm 365:89CrossRef
26.
Zurück zum Zitat Khodaverdi E, Tekie FSM, Mohajeri SA, Ganji F, Zohuri G, Hadizadeh F (2012) AAPS PharmSciTech 13:590CrossRef Khodaverdi E, Tekie FSM, Mohajeri SA, Ganji F, Zohuri G, Hadizadeh F (2012) AAPS PharmSciTech 13:590CrossRef
27.
Zurück zum Zitat Bennett DB, Li X, Adams N, Kim S, Hoes C, Feijen J (1991) J Control Release 16:43CrossRef Bennett DB, Li X, Adams N, Kim S, Hoes C, Feijen J (1991) J Control Release 16:43CrossRef
28.
Zurück zum Zitat Salehi R, Davaran S, Rashidi MR, Entezami AA (2009) J Appl Polym Sci 111:1905CrossRef Salehi R, Davaran S, Rashidi MR, Entezami AA (2009) J Appl Polym Sci 111:1905CrossRef
29.
Zurück zum Zitat Khodaverdi E, Hadizadeh F, Tekie FSM, Jalali A, Mohajeri SA, Ganji F (2012) Polym Bull 69:429CrossRef Khodaverdi E, Hadizadeh F, Tekie FSM, Jalali A, Mohajeri SA, Ganji F (2012) Polym Bull 69:429CrossRef
Metadaten
Titel
Sustained release drug delivery using supramolecular hydrogels of the triblock copolymer PCL–PEG–PCL and α-cyclodextrin
verfasst von
Sayyed A. Sajadi Tabassi
Farnaz Sadat Mirzazadeh Tekie
Farzin Hadizadeh
Rahof Rashid
Elham Khodaverdi
Seyed Ahmad Mohajeri
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Journal of Sol-Gel Science and Technology / Ausgabe 1/2014
Print ISSN: 0928-0707
Elektronische ISSN: 1573-4846
DOI
https://doi.org/10.1007/s10971-013-3200-9

Weitere Artikel der Ausgabe 1/2014

Journal of Sol-Gel Science and Technology 1/2014 Zur Ausgabe

    Marktübersichten

    Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.